Scancell Holdings plc (LON:SCLP – Get Free Report) shares hit a new 52-week low on Wednesday . The stock traded as low as GBX 8.53 ($0.11) and last traded at GBX 8.53 ($0.11), with a volume of 153344 shares changing hands. The stock had previously closed at GBX 8.90 ($0.11).
Scancell Stock Down 4.2 %
The company’s 50 day simple moving average is GBX 9.96 and its 200-day simple moving average is GBX 13.21. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42. The firm has a market capitalization of £88.35 million, a PE ratio of -13.08 and a beta of 0.35.
Scancell (LON:SCLP – Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. On average, analysts forecast that Scancell Holdings plc will post -2.5361112 EPS for the current fiscal year.
About Scancell
Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
Recommended Stories
- Five stocks we like better than Scancell
- Why Are Stock Sectors Important to Successful Investing?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What to Know About Investing in Penny Stocks
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Roth IRA Calculator: Calculate Your Potential Returns
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.
